More on SLXN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-427.8% Growth)
- Ratings (5.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Silexion Therapeutics (NQ:SLXN)
Delayed: 0.25 -0.01 (3.85%)
Prev. Close $0.26  
Open$0.25 
52 Wk High$0.10 
52 Wk Low$0.05 
Day High$0.26 
Day Low$0.25 
P/E N/A  
EPS$-0.09 
Volume408,480 


Oct 5, 2026 04:09 PM Form DEF 14A Silexion Therapeutics For: Oct 05
Sep 30, 2026 08:52 AM Form 8-K Silexion Therapeutics For: Sep 30
Sep 30, 2026 08:01 AM Silexion doses first patient in Phase 2/3 pancreatic cancer trial
Sep 30, 2026 08:00 AM Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Sep 29, 2026 10:35 AM Form 424B3 Silexion Therapeutics
Sep 29, 2026 10:31 AM Form 8-K Silexion Therapeutics For: Sep 28
Sep 29, 2026 08:05 AM Silexion Therapeutics exercises series E warrants for $837K
Sep 29, 2026 08:03 AM Silexion Therapeutics Announces Exercise of Warrants
Sep 28, 2026 04:29 PM Form SCHEDULE 13D/A Silexion Therapeutics Filed by: Moringa Sponsor, LP
Sep 28, 2026 08:46 AM Form 8-K Silexion Therapeutics For: Sep 28
View All Articles

Entities mentioned with SLXN

View All Entities